FDA Inspection 846264 — Blood Center Of New Jersey, The

Blood Center Of New Jersey, The — FEI 2270831

The FDA completed an inspection of Blood Center Of New Jersey, The on Aug 29, 2013 in East Orange, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 29, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
East Orange, NJ (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
922521 CFR 606.171Biological product deviation report
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.